MedTrace Logo

Reproductive Outcome After Sperm Selection for Intracytoplasmic Sperm Injection (ICSI) Using Zona Pellucida Proteins

NCT05161247 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 368

Last updated 2025-05-21

No results posted yet for this study

Summary

The aim of this study is to analyze the effect of a sperm selection method by adhesion to partners' zona pellucida proteins on the assisted reproduction treatment (ART) outcome parameters.

Conditions

  • Infertility, Male

Interventions

OTHER

Zona pellucida sperm selection

Sperm selection for ICSI based on the spermatozoa ability to adhere to immobilized zona pellucida proteins.

OTHER

Conventional sperm selection

Sperm selection for ICSI based on the sperm morphology.

OTHER

Intracytoplasmic Sperm Injection (ICSI)

Normal ICSI procedure.

Sponsors & Collaborators

  • Nadezhda Women's Health Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-03
Primary Completion
2024-03-03
Completion
2024-07-05

Countries

  • Bulgaria

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05161247 on ClinicalTrials.gov